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ABSTRACT 20 
 21 
Zinc oxide (ZnO) is a semiconductor compound with a potential for wide use in various 22 
applications, including biomaterials and biosensors, particularly as nanoparticles (the size 23 
range of ZnO nanoparticles is from 2 to 100 nm, with an average of about 35 nm). Here, we 24 
report isolation of novel ZnO-binding peptides, by using screening of a phage display library. 25 
Interestingly, amino acid sequences of the ZnO-binding peptides reported in this paper and 26 
those described previously are significantly different. This suggests that there is a high 27 
variability in sequences of peptides which can bind particular inorganic molecules, indicating 28 
that different approaches may lead to discovery of different peptides of generally the same 29 
activity (e.g. binding of ZnO) but having various detailed properties, perhaps crucial under 30 
specific conditions of different applications.   31 
 32 
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INTRODUCTION 41 
 42 
Zinc oxide (ZnO) is a compound widely used in many applications, including 43 
construction of solar cells, luminescent materials and acoustic devices (Goyal et al. 1992; 44 
Ezhilvalavan and Kutty 1997; Yu et al. 2005; Shinde et al. 2007). Interestingly, employment 45 
of ZnO in biosensors has also been proposed (Gerstel et al. 2006; Park et al. 2009; Tomczak 46 
et al. 2009). The possibility to obtain ZnO nanoparticles (i.e. the structures whose at least one 47 
dimension is less than 100 nm) significantly broads its practical usefulness (Fan and Lu 48 
2005).  It appears that ZnO nanoparticles (which are usually in the size range between 2 and 49 
100 nm, with an average of about 35 nm; Meulenkamp 1998) may be of special interest in 50 
biotechnology and nanotechnology (Umetsu et al. 2005; Okochi et al. 2010). In fact, ZnO 51 
nanomaterials have been used in sensors, field emission devices, photodetectors and optical 52 
switches (for a review, see Weintraub et al. 2010). Medical applications of ZnO nanoparticles 53 
are facilitated due to consideration of zinc oxide as a safe material, and include anticancer 54 
agents, antimicrobial factors and drug delivery systems (discussed by Li et al. 2008 and 55 
Rasmussen et al. 2010). Since ZnO nanoparticles can absorb UV light, they are used in 56 
cosmetics, particularly in face or body sunscreen creams (Rasmussen et al. 2010).   57 
The wide use of ZnO nanoparticles stimulated the search for compounds that may 58 
specifically bind such structures. In fact, agents that can bind inorganic compounds may be 59 
used to build materials with nanoscale precision. Peptides and proteins were demonstrated to 60 
be particularly useful in this approach, even when applied to substances not commonly found 61 
in biological systems (Brown et al. 2000). Therefore, knowing an extremely high variability 62 
of properties of peptides and proteins, and a potential possibility to obtain a peptide that might 63 
bind any small molecule of interest, it is reasonable to search for peptides specifically 64 
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interacting with certain compounds (Seker and Demir 2011). One of the most effective 65 
methods in such a search, especially if a target material forms nanoparticles, is screening of 66 
peptide libraries (Seker and Demir 2011). 67 
Phage display technique is a method which allows production of various peptides 68 
attached to the surface proteins of bacteriophage virions (Castel et al. 2011). This is achieved 69 
by genetic engineering of the bacteriophage genome, particularly by fusing genes coding for 70 
phage structural proteins with an appropriate DNA fragment, coding for the desired protein or 71 
peptide. This may concern either a specific peptide or protein of known functions or a 72 
putative one. In the latter case, DNA fragments of randomized sequences can be cloned, and 73 
their expression leads to formation of a peptide library, expressed on the bacteriophage 74 
surface. Derivatives of phage M13 are among the most widely used vectors in phage display 75 
systems (Georgieva and Konthur 2011).   76 
Previously, several ZnO-binding peptides have been reported, which were isolated on 77 
the basis of various approaches, including screening of peptide libraries expressed in phage 78 
display systems (Kjaergaard et al. 2000; Umetsu et al. 2005; Okochi et al. 2010; Vreuls et al. 79 
2010). Amino acid sequences of these peptides are listed in Table 1. We wanted to probe 80 
whether amino acid sequences of ZnO-binding peptides are strictly determined (i.e. the 81 
number of possible kinds of ZnO-binding peptides of various sequences is strictly limited) or 82 
whether there are many possibilities to form such peptides, whose sequences are significantly 83 
different. If the former alternative is true, any new attempts to obtain ZnO-binding peptides 84 
should result in obtaining results similar to those published to date. On the other hand, if the 85 
latter option is correct, new experiments, differing even slightly in details, should result in 86 
isolating peptides which bind ZnO but have amino acid sequences significantly different from 87 
those already reported. 88 
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 89 
MATERIALS AND METHODS 90 
  91 
Peptide phage library 92 
To isolate novel ZnO-binding peptides, we have employed a peptide phage library that 93 
displays a linear 12-mer peptide on the pIII protein of M13KE phage (Ph.D.-12 Phage 94 
Display Peptide Library Kit, New England Biolabs, NEB). This system was successfully used 95 
previously to find material-specific peptides (Whaley et al. 2000; Chen et al. 2006; Ahmad et 96 
al. 2008).  97 
 98 
Selection and characterization of bacteriophages presenting ZnO-binding peptides 99 
To select bacteriophages presenting ZnO-binding peptides on their surfaces, we have 100 
utilized synthetic, physically powdered ZnO (Sigma-Aldrich). Panning procedure was 101 
performed according to the Phage Display Manual (NEB). Briefly, 10 mg of ZnO powder 102 
were washed 6 times with the TBST buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% 103 
Tween-20) to remove any ZnO particles that do not sediment during centrifugation at 4000 g 104 
for 1 min (which would negatively interfere with phage isolation at later steps of the 105 
procedure) and to establish the equilibrium of buffer conditions of the mixture (which is 106 
crucial for effective binding of phages to any surface). 10 µl of phage library were incubated 107 
with ZnO in 1 ml of the TBST buffer (at final ZnO concentration of 10 mg/ml) for 1 hour at 108 
room temperature (RT). This incubation time was chosen on the basis of results of 109 
preliminary experiments, in which shorter incubation was less efficient in isolating ZnO-110 
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binding phages, while extending the time over 1 h did not change the results significantly. 111 
Unbound phages were then separated from ZnO-binding phages by centrifugation (4000 g, 1 112 
min, RT) and were subsequently removed by decanting the supernatant. The pellet containing 113 
ZnO with bound phages was washed 10 times with the TBST buffer. Phages which bound 114 
ZnO were eluted with 1 ml of 0.2 M glycine-HCl (pH 2.2) for 10 min, and finally neutralized 115 
with 150 µl of 1 M Tris-HCl (pH 9.1). Phages were then multiplied on Escherichia coli 116 
ER2738 (NEB) according to the NEB protocol and used in the next panning procedure 117 
(briefly, for phage multiplication, 0.2 ml of an overnight E. coli ER2738 culture were mixed 118 
with eluted phages, transferred to 20 ml of fresh LB medium in a 250 ml flask, and incubated 119 
with shaking (160 rpm) at 37
o
C for 5 h). Three rounds of panning were performed. Following 120 
the last panning, the eluted phages were titrated on agar plates supplemented with IPTG/XGal 121 
as previously described (Łoś et al. 2008). Phages from individual plaques were amplified as 122 
described above, and their DNAs were isolated and purified according to Wilson (1993) and 123 
sequenced commercially using the 96 gIII sequencing primer (NEB). 124 
 125 
RESULTS AND DISCUSSION 126 
 127 
Experiments performed as described in Materials and Methods led to detection of a 128 
huge variability (in the range of a few to several orders of magnitude) in efficiencies of 129 
binding to ZnO nanoparticles exhibited by different phage clones, as estimated by 130 
determining percentages of bound and unbound virions after 1 h incubaction. In fact, some 131 
binding (several percent of bound virions) could be observed even for phages that did not 132 
expose any foreign peptides on their capsids (data not shown). This might be explained by the 133 
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fact that no chemical surface could be truly neutral in its effects on adhesion, thus, even 134 
naturally occurring phages may attach, to some extent, to any particles. Nevertheless, we have 135 
isolated 20 phage clones which were able to bind ZnO very efficiently, i.e. in which at least 136 
99.99% virions were able to interact with ZnO sufficiently stably to remain bound after the 137 
washing procedures.  138 
Of the isolated 20 clones, those revealing the highest affinity to ZnO (clones no. PG-7, 139 
PG-8, PG-10, PG-12, PG-14, PG-17) were chosen for more detailed analysis, in which 140 
nucleotide sequences of the DNA inserts have been determined. As a semi-negative control, a 141 
clone revealing about 10 times lower affinity to ZnO (measured as a fraction of virions able to 142 
remain bound after the washing procedures), called clone no. PG-2, was also analyzed (Fig. 143 
1). Amino acid sequences of peptides PG-7, PG-8, PG-12, PG-14 and PG-17, exposed on the 144 
phage surface, deduced on the basis of determined nucleotide sequences, were identical and 145 
red as follows: TMGANLGLKWPV (Fig. 1, Table 1). The amino acid sequence of PG-10 146 
was TTGANLGPKWPV, and that of PG-2 was TMGANLGLESPE. Comparison of the 147 
differences between clones binding ZnO relatively strongly (i.e. consisting of less than 1 per 148 
10
5
 virions unbound to ZnO, giving the efficiency of binding >99.999%; clones PG-7, PG-8, 149 
PG-12, PG-14 and PG-17) with those binding ZnO slightly (clone PG-10) or significantly 150 
(clone PG-2) weaker indicated that the optimal amino acid sequence of ZnO-binding peptide, 151 
isolated under conditions employed in this study, was as follows: TMGANLGLKWPV (Fig. 152 
1). Moreover, it appears that replacement of M with T at position 2 and of L with P at position 153 
8 (as in PG-10) had a minor effect on ZnO binding, while replacement of K with E at position 154 
9, W with S at position 10, and of V with E at position 12 (as in PG-2), resulted in a 155 
considerable lower affinity of the peptide to ZnO (Fig. 1).  156 
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The clone no. PG-7 (revealing the optimal ZnO-binding sequence of the phage 157 
surface-exposed peptide), has been further characterized. We assessed the efficiency of ZnO 158 
binding according to the panning procedure (Sano and Shiba 2003). Binding efficiency was 159 
expressed as the ratio of the output phage number (phages eluted, O) to the input phage 160 
number (phages incubated with ZnO, I), called the output/input (O/I) ratio. As a control, we 161 
employed the M13KE phage with the wild-type pIII protein (NEB). The results of such 162 
experiments, presented in Fig. 2, confirmed an efficient binding of the selected peptide to 163 
ZnO. This efficiency appears to be similar to those described previously for other peptides 164 
isolated as agents that bind ZnO effectively (Kjaergaard et al. 2000; Umetsu et al. 2005; 165 
Okochi et al. 2010; Vreuls et al. 2010). 166 
The results of experiments presented in this report indicate that by changing either 167 
experimental conditions or approach, it is possible to isolate ZnO-binding peptides of very 168 
different amino acid sequences (compare sequences of ZnO-binding peptides presented in 169 
Table 1). Therefore, it appears that variability of peptide structures that are able to bind this 170 
compound is very high. This implies potential possibilities of searching for ZnO-binding 171 
peptides revealing various properties under different reaction conditions. In this light, it is 172 
worth reminding that different applications of ZnO may require binding of this compound by 173 
peptides under various conditions of temperature, pH, ionic strength and others (Umetsu et al. 174 
2005).  175 
Finally, one should note that searching for factors that can bind certain compounds, 176 
particularly when using the method of phage display-based screening of peptide libraries, is 177 
devoted to bio- and bionano-technological applications, and in no way represents processes 178 
that occur in nature. The phage display tests demonstrate a huge biological potential of 179 
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organisms rather than mimic actual biological selection, at least under conditions currently 180 
occurring in natural habitats. 181 
 182 
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 301 
Table 1. Sequences of ZnO-binding peptides identified in this report and in previously published ones. 302 
Peptide name Amino acid sequence pI
a 
Remarks Reference 
PG-2 TMGANLGLESPE 3.79 Affinity of PG-2 to ZnO is at least 10 times lower than 
those of PG-7, PG-8, PG-10, PG-12, PG-14 and PG-17 
This report 
PG-7 TMGANLGLKWPV 8.41 The consensus sequence determined in this report This report 
ZnO-1 EAHVMHKVAPRP 8.86 Affinity of ZnO-1 to ZnO is at the same level as that of 
PG-7 
(Umetsu et al. 2005) 
ZnO-2 QNTATAVSRLSP 9.75 Affinity of ZnO-2 to ZnO is at least 100 times lower than 
that of ZnO-1 
(Umetsu et al. 2005) 
ZnO-3 ATHTNQTHALYR 8.80 Affinity of ZnO-3 to ZnO is at least 100 times lower than 
that of ZnO-1 
(Umetsu et al. 2005) 
ZnO-4 VSNHKALDYPTR 8.57 Affinity of ZnO-4 to ZnO is at least 100 times lower than 
that of ZnO-1 
(Umetsu et al. 2005) 
ZnO-5 DSGRYSMTNHYS 6.74 Affinity of ZnO-5 to ZnO is at least 100 times lower than 
that of ZnO-1 
(Umetsu et al. 2005) 
ZnO Okochi-1
(b) 
HVNLHS 6.92 Affinity of ZnO Okochi-1 to ZnO is at the same level as 
that of ZnO-1 
(Okochi et al. 2010) 
ZnO Okochi-2
(b)
 RCARRY 10.76 Affinity of ZnO Okochi-2 to ZnO is at the same level as 
that of ZnO-1 
(Okochi et al. 2010) 
ZnO Okochi-3
(b)
 HYQSNW 6.74 Affinity of ZnO Okochi-3 to ZnO is at the same level as 
that of ZnO-1 
(Okochi et al. 2010) 
ZnO Okochi-4
(b)
 HWFHPR 9.76 Affinity of ZnO Okochi-4 to ZnO is at the same level as 
that of ZnO-1 
(Okochi et al. 2010) 
ZnO-binding 
peptide
(b)
 
VRTRDDARTHRK 11.54 This peptide has been found with the use of the FimH 
display system 
(Kjaergaard et al. 2000; 
Vreuls et al. 2010) 
 303 
(a) Isoelectric point had been calculated using pI/mass program at http://ca.expasy.org. 304 
(b) Names have been given by authors of this work, as no specific names were used in the original publications. 305 
 306 
 307 
 308 
16 
 
 309 
Figure legends 310 
 311 
Fig. 1. Characterization of selected phage clones which expose ZnO-binding peptides on their 312 
virion surfaces. Names of clones and sequences of the exposed peptides are shown, with 313 
differences in amino acid residues between peptides marked by white letters on the black 314 
background. Efficiency of ZnO binding by particular phage clones was estimated by 315 
determination of the fraction of virions unbound to ZnO after the washing procedure (see 316 
Materials and Methods for details). 317 
 318 
Fig. 2. Efficiency of ZnO binding by the phage exposing the PG-7 peptide on the pIII protein 319 
of the M13KE phage. In the control experiments, the unmodified M13KE phage was used. 320 
The presented results are average values from 3 experiments with SD represented by error 321 
bars. 322 
 323 
 324 
 325 
 326 
 327 
 328 
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 329 
 330 
      Fraction of   Efficiency of 331 
    ZnO-unbound  ZnO binding 332 
    virions   (% of phages) 333 
 334 
PG-2:  TMGANLGLESPE  1.33 x 10-4       99.99   335 
PG-7:  TMGANLGLKWPV  < 1 x 10-5    > 99.999 336 
PG-8:  TMGANLGLKWPV  < 1 x 10-5    > 99.999 337 
PG-10: TTGANLGPKWPV  1.16 x 10-5     99.998 338 
PG-12: TMGANLGLKWPV  < 1 x 10-5   > 99.999 339 
PG-14: TMGANLGLKWPV  < 1 x 10-5   > 99.999 340 
PG-17: TMGANLGLKWPV  < 1 x 10-5   > 99.999 341 
________________________________________________________________ 342 
Consensus: TMGANLGLKWPV     > 99.999 343 
 344 
 345 
 346 
 347 
 348 
Figure 1 349 
 350 
 351 
 352 
 353 
 354 
 355 
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Figure 2 361 
 362 
 363 
